RBC Capital Maintains Outperform on Xylem, Raises Price Target to $162
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Deane Dray maintains an Outperform rating on Xylem (NYSE:XYL) and raises the price target from $157 to $162.
May 03, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Deane Dray maintains an Outperform rating on Xylem and raises the price target from $157 to $162.
The increase in price target by RBC Capital reflects a positive outlook on Xylem's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100